Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Patient-Centred Outcomes Research, Medical Clinic, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Qual Life Res. 2023 Sep;32(9):2477-2487. doi: 10.1007/s11136-023-03404-2. Epub 2023 Apr 9.
The European Organisation for Research and Treatment of Cancer (EORTC) quality of life core questionnaire (QLQ-C30) is a validated and widely-used Patient-Reported Outcome Measure for measuring the health-related quality of life (HRQoL) of cancer patients. To facilitate interpretation of results obtained in studies using the EORTC QLQ-C30, we generated normative data for the Dutch general population, stratified by age and sex.
Dutch participants were selected from a larger cross-sectional online panel research study collecting EORTC QLQ-C30 general population normative data across 15 countries. EORTC QLQ-C30 raw scores based on a 4-point response scale were transformed to linear scores ranging from 0 to 100. Transformed scores were weighted based on the United Nations population distribution statistics and presented by age and sex/age. Differences in scale scores of ≥ 10 points in HRQoL were applied to indicate clinical relevance.
One thousand respondents completed the online survey. Stratified by age, clinically meaningful differences were observed, with worse physical functioning scores and better emotional functioning scores with increased age. Symptom scores remained stable across age groups, except for small age differences observed for fatigue, nausea/vomiting, diarrhoea, and financial difficulties. Stratified by sex/age, men generally scored better for both functioning and symptoms. However, these differences were not clinically meaningful.
These updated normative EORTC QLQ-C30 for the Dutch general population can be used to better interpret HRQoL data obtained from Dutch cancer patients. Being part of a larger international study, these data can further be used for inter-country comparisons in multi-national studies.
欧洲癌症研究与治疗组织(EORTC)生活质量核心问卷(QLQ-C30)是一种经过验证并广泛使用的患者报告结局测量工具,用于测量癌症患者的健康相关生活质量(HRQoL)。为了便于解释使用 EORTC QLQ-C30 进行的研究结果,我们为荷兰一般人群生成了按年龄和性别分层的规范数据。
从一项更大的横断面在线小组研究中选择了荷兰参与者,该研究在 15 个国家收集 EORTC QLQ-C30 一般人群规范数据。基于 4 分制反应量表的 EORTC QLQ-C30 原始分数转换为线性分数,范围从 0 到 100。转换后的分数基于联合国人口分布统计数据进行加权,并按年龄和性别/年龄呈现。HRQoL 中差异≥10 分的量表评分用于表示临床相关性。
1000 名受访者完成了在线调查。按年龄分层,观察到具有临床意义的差异,随着年龄的增长,身体功能评分变差,情绪功能评分变好。除了疲劳、恶心/呕吐、腹泻和经济困难方面观察到的小年龄差异外,症状评分在整个年龄组中保持稳定。按性别/年龄分层,男性在功能和症状方面的评分通常更好。然而,这些差异没有临床意义。
这些更新的荷兰一般人群 EORTC QLQ-C30 规范数据可用于更好地解释从荷兰癌症患者中获得的 HRQoL 数据。作为更大的国际研究的一部分,这些数据可进一步用于多国研究中的国家间比较。